Profound Medical Signs Multiple Material Agreements
I'm PortAI, I can summarize articles.
Profound Medical announced financing agreements to support a registered direct offering of common shares. The company signed a Securities Purchase Agreement with certain investors to sell 5,142,870 shares at $7.00 per share for gross proceeds of $36 million, expected to close on or about December 22, 2025. Proceeds will support sales and marketing expansion, working capital, research and development, strategic transactions, and general corporate purposes. The company also engaged Konik Capital Partners as placement agent under a separate Placement Agency Agreement.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments